Molecular Quality Controls Market Outstrip US$ 372.64 million in 2028 COVID-19 Impact and Global Analysis By Product, Application, and Geography

Molecular Quality Controls Market: Insight

The molecular quality controls market is expected to reach US$ 372.64 million in 2028 from US$ 184.62 million in 2021; it is estimated to grow at a CAGR of 10.6% during 2021–2028.

Molecular quality controls help to monitor the performance of testing procedures. These tests are helpful to achieve critical and accurate diagnostic information. These controls are used to determine transmissible and genetic diseases too. Moreover, the molecular quality controls also help to monitor the performance of nucleic acid testing protocols for healthcare associated infections, viral load assays and sexually transmitted infections. The growth of the molecular quality controls market is attributed to the factors such as growing funds for genomics, declining cost of sequencing procedures, and increasing prevalence of genetic diseases fuel the growth of the market. However, the dearth of skilled professionals hinders the market growth. 

Download sample PDF Copy of Molecular Quality Controls Market study at: https://www.theinsightpartners.com/sample/TIPRE00005166/

Molecular Quality Controls Market Competitive Landscape

Thermo Fisher Scientific Inc; Bio-Rad Laboratories Inc; F. Hoffmann la-Roche Ltd; Abbott; Quidel Corporation; Qnostics; Maine Molecular Controls Inc; Zeptometrix Corporation; Microbiologics, and Seracare Life Sciences are among the leading companies operating in the molecular quality controls market.

Increasing Prevalence of Genetic Diseases

Molecular quality controls are used to detect genetic diseases as these aid in the interpretation of results. Downs Syndrome is a genetic disorder that causes due to abnormal cell division, which results in an extra full or partial copy of chromosome 21. As per the US Centers for Disease Control and Prevention (CDC), every year, around 6,000 newborns in the US suffer from the Down syndrome. As a result, prenatal testing for Down syndrome is increasing in the country.

Most of the inherited cases of breast cancer are associated with mutations in two genes: BRCA1 (BReast CAncer gene one) and BRCA2 (BReast CAncer gene two). As per the American Cancer Society, around 5% to 10% of breast cancer cases are hereditary, as a result of mutated genes passed from parent to children. Growing awareness of breast cancer increases the adoption of genetic testing for hereditary breast cancer.

Further, as per CDC, sickle cell disease (SCD) is a common genetic blood disorder in the US that affects ~70,000 to 100,000 Americans. Further, as per the WHO, 5% of the world population is the carrier of the genes for hemoglobin disorders, such as sickle-cell disease and thalassemia. Thus, the increasing prevalence of such genetic diseases propels the demand for molecular quality controls.

The report segments the molecular quality controls market as follows:

 By Product

  • Independent Controls
  • Instrument Specific Controls

By Analyte Type

  • Single Analyte Controls
  • Multi Analyte Controls

By Application

 

  • Infectious Diseases
  • Oncology
  • Genetic Testing
  • Other Applications

By End User

 

  • Clinical Laboratories
  • Hospitals
  • IVD Manufacturers & Contract Research Organizations
  • Academic & Research Institutes
  • Other End Users

By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • UK
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Middle East and Africa (MEA)
    • Saudi Arabia
    • UAE
    • South Africa
    • Rest of Middle East and Africa
  • South and Central America (SCAM)
    • Brazil
    • Argentina
    • Rest of South and Central America

Buy Complete Report of molecular quality controls market Study at: https://www.theinsightpartners.com/buy/TIPRE00005166/

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

We are committed to provide highest quality research and consulting services to our customers. We help our clients understand the key market trends, identify opportunities, and make informed decisions with our market research offerings at an affordable cost.

Contact Us

Contact Person: Sameer Joshi

Phone: +1-646-491-9876

E-mail: sam@theinsightpartners.com

Back to news